Form 6-K Huazhu Group Ltd For: May 17
http://archive.fast-edgar.com/20220517/ANB2C62C8Z22KZZ222TO2ZZZJ9ST72Q2D242
Filed on: May 17, 2022
Form D/A WORKING CAPITAL PARTNERS
http://archive.fast-edgar.com/20220517/AK22I22C622282Z2222N224Z4R29H2G29242
Filed on: May 17, 2022
Form 8-K Royalty Pharma plc For: May 17
Exhibit 99.1
ROYALTY PHARMA INVESTOR DAY HIGHLIGHTS STRONGER GROWTH OUTLOOK AND THE POWER OF ITS UNIQUE BUSINESS MODEL TO DRIVE VALUE FOR ALL STAKEHOLDERS
New capital deployment target of $10-12 billion over the next five years
Outlook for 2020-2025 Adjusted Cash Receipts (1) (non-GAAP) CAGR raised to 11-14%
Adjusted Cash Receipts (1) (non-GAAP) expected to grow 10% or more over this decade, positioning Royalty Pharma to... (continue reading...)
Form MA-A Comer Capital Group, For: Dec 31
MA-A
0001616021
XXXXXXXX
Comer Capital Group, LLC
769-257-5039-701
[email protected]
[email protected]
12-31-2021
Y
Comer Capital Group, LLC
26-3010830
866-00009-00
867-00360
1880 LAKELAND DRIVE, SUITE C
JACKSON
... (continue reading...)
Form 4 Prestige Consumer Health For: May 13 Filed by: Mekhail Adel
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Ensysce Biosciences, For: May 17
-
Form NT 10-Q BIMI International Medic For: Mar 31
-
Form 6-K Mountain Province Diamon For: May 17
-
Form 8-K RH For: May 13
-
Form 8-K Intercontinental Exchang For: May 13
-
Form 8-K HighPeak Energy, Inc. For: May 17
-
Form 8-K BIO-PATH HOLDINGS INC For: May 17
-
Form 8-K CYTOKINETICS INC For: May 17
-
Form 8-K ZW Data Action Technolog For: May 17
-
Form 6-K REE Automotive Ltd. For: May 17
-
Form 6-K Cardiol Therapeutics For: May 17
-
Form 10-Q/A Bunker Hill Mining Corp. For: Mar 31
-
Form 10-Q/A Logicquest Technology, For: Mar 31
-
Form 8-K Aquestive Therapeutics, For: May 13
-
Form 10-Q WORLD HEALTH ENERGY HOLD For: Mar 31
-
Form 425 PROPTECH INVESTMENT CORP Filed by: PROPTECH INVESTMENT CORP. II
-
Form 6-K SMITH & NEPHEW PLC For: May 17
-
Form 6-K JD.com, Inc. For: May 17
-
Form NT 10-Q WORLD HEALTH ENERGY HOLD For: Mar 31
-
Form TA-1/A DB SERVICES AMERICAS
-
Form 8-K PROPTECH INVESTMENT CORP For: May 17
-
Form 6-K ING GROEP NV For: May 17
-
Form 8-K AVROBIO, Inc. For: May 17
-
Form 8-K EMPIRE PETROLEUM CORP For: May 17
-
Form 6-K mCloud Technologies Corp For: Mar 31
-
Form 424B3 Janus International Grou
-
Form 6-K MediWound Ltd. For: May 17
-
Form 6-K PARTNER COMMUNICATIONS For: May 17
-
Form 4 MPLX LP For: May 13 Filed by: SURMA JOHN P
-
Form 6-K KAMADA LTD For: May 17
-
Form 8-K Janus International Grou For: May 17
-
Form 6-K Burford Capital Ltd For: May 17
-
Form 6-K ANGLOGOLD ASHANTI LTD For: May 17
-
Form 4 MPLX LP For: May 13 Filed by: STICE J MICHAEL
-
Form 4 MPLX LP For: May 13 Filed by: SEMPLE FRANK M
-
Form S-8 Immunocore Holdings plc
-
Form 6-K HeadHunter Group PLC For: May 17
-
Form 6-K Vascular Biogenics Ltd. For: Mar 31
-
Form 6-K Pacific Airport Group For: May 17
-
Form 6-K KAMADA LTD For: May 17
-
Form 6-K Caledonia Mining Corp For: May 17
-
Form 6-K ObsEva SA For: May 17
-
Form 4 MPLX LP For: May 13 Filed by: SANDMAN DAN D
-
Form 8-K Walmart Inc. For: May 17
-
Form 4 MPLX LP For: May 13 Filed by: Peiffer Garry L.
-
Form 8-K Yale Transaction Finders For: May 16
-
Form NT 10-Q KIORA PHARMACEUTICALS For: Mar 31
-
Form 4 MPLX LP For: May 13 Filed by: HELMS CHRISTOPHER A
-
Form 6-K EMERA INC For: May 17
-
Form 8-K HOLLY ENERGY PARTNERS For: May 17